HQL

abrdn Life Sciences Investors
HQL

Overview Fund Trends Analyst Outlook Journalist POV

41 hedge funds and large institutions have $47.6M invested in abrdn Life Sciences Investors in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

16% less funds holding

Funds holding: 49 → 41 (-8)

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$747K
2
+$363K
3
+$363K
4
LPL Financial
LPL Financial
California
+$358K
5
FHA
Flagship Harbor Advisors
Massachusetts
+$264K

Top Sellers

1
-$952K
2
-$461K
3
-$437K
4
DA
Doliver Advisors
Texas
-$433K
5
Stifel Financial
Stifel Financial
Missouri
-$325K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$219K
27
$212K
28
$198K
29
$194K
30
$59K
31
$51K
32
$44K
33
$40K
34
$26K
35
$25K
36
$21K
37
$19K
38
$13K
39
$10K
40
$1K
41
–
42
–
43
–
44
–
45
–
46
–
47
–
1
2